NPHCDA Immunization FHIR IG
0.7.0 - ci-build
NPHCDA Immunization FHIR IG
0.7.0 - ci-build
NPHCDA Immunization FHIR IG, published by https://nphcda.gov.ng. This guide is not an authorized publication; it is the continuous build for version 0.7.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/Nigeria-FHIR-Community/NPHCDA-ImmunizationIG/ and changes regularly. See the Directory of published versions
Profile: NG-Imm AllergyIntolerance
NG-Imm Allergy Dose Number: 457
NG-Imm Dose Series: Measles Infant Series
clinicalStatus: Resolved
verificationStatus: Confirmed
type: Allergy
category: Medication, Biologic
criticality: Low Risk
code: Measles morbillivirus and Rubella virus antigens only vaccine product
patient: Tolu Oluwatobi Adeyemi Male, DoB: 2022-09-21 ( MRN)
onset: 2025-07-20 10:45:00+0100
recordedDate: 2025-07-20 11:30:00+0100
recorder: Practitioner Musa Abdullahi
lastOccurrence: 2025-07-21 08:00:00+0100
reaction
substance: Measles vaccine
manifestation: Fever, Maculopapular rash
description: Fever (38.5 °C) and rash developed within 24 hours after measles vaccine.
onset: 2025-07-20 18:00:00+0100
severity: Mild